DSMM XI study: dose definition for intravenous cyclophosphamide in combination with bortezomib/dexamethasone for remission induction in patients with newly diagnosed myeloma

A clinical trial was initiated to evaluate the recommended dose of cyclophosphamide in combination with bortezomib and dexamethasone as induction treatment before stem cell transplantation for younger patients with newly diagnosed multiple myeloma (MM). Thirty patients were treated with three 21-day...

Descripción completa

Detalles Bibliográficos
Autores principales: Kropff, Martin, Liebisch, Peter, Knop, Stefan, Weisel, Katja, Wand, Hannes, Gann, Claudia-Nanette, Berdel, Wolfgang E., Einsele, Herrmann
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745621/
https://www.ncbi.nlm.nih.gov/pubmed/19274460
http://dx.doi.org/10.1007/s00277-009-0726-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745621/
https://www.ncbi.nlm.nih.gov/pubmed/19274460
http://dx.doi.org/10.1007/s00277-009-0726-6

Ejemplares similares